Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Chronic myelogenous leukemia molecular signature

Oncogene volume 22, pages 3952–3963 (2003)Cite this article

Abstract

To obtain comprehensive information about the genes involved in BCR/ABL-dependent leukemogenesis, samples from 15 chronic myelogenous leukemia (CML) patients and seven normal donors were analysed using a cDNA microarray assay. After subtraction of the artificial, random or cross-hybridization signals, data about 5315 genes have been effectively analysed in all samples. The assay revealed ⩾4-fold difference in the average expression of 263 genes in all CML samples when compared to normal counterparts, with 148 genes being upregulated and 115 being downregulated. Differentially expressed genes include those associated with BCR/ABL-induced abnormalities in signal transduction, gene transactivation, cell cycle, apoptosis, adhesion, DNA repair, differentiation, metabolism and malignant progression. Interestingly, CML-blast crisis cells in peripheral blood differ from those from bone marrow, indicating major changes in gene expression profiles upon entering into the bloodstream. Moreover, BCR/ABL modulates expression of genes, which are involved in regulation of chromosome/chromatin/DNA dynamics during S and M cell cycle phase. Moreover, the ability of CML cells to recognize and respond to a pathogen infection may be compromised. Altogether, this work provides a large body of information regarding gene expression profiles associated with CML and also represents a source of potential targets for CML therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Afar DE, McLaughlin J, Sherr CJ, Witte ON and Roussel MF . (1995). Proc. Natl. Acad. Sci. USA, 92, 9540–9544.

  • Ahuja H, Bar-Eli M, Arlin Z, Advani S, Allen SL, Goldman J, Snyder D, Foti A and Cline M . (1991). J. Clin. Invest., 87, 2042–2047.

  • Akiyama H, Maruyama T, Uetake T, Kawaguchi K, Sakamaki H and Onozawa Y . (1991). Rev. Infect. Dis., 13, 815–818.

  • Aristarkhov A, Eytan E, Moghe A, Admon A, Hershko A and Ruderman JV . (1996). Proc. Natl. Acad. Sci. USA, 93, 4294–4299.

  • Behrens P, Brinkmann U, Fogt F, Wernert N and Wellmann A . (2001). Anticancer Res., 21, 2413–2417.

  • Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD and Witte ON . (1988). Science, 239, 775–777.

  • Cortez D, Reuther G and Pendergast AM . (1997). Oncogene, 15, 2333–2342.

  • Daley GQ and Baltimore D . (1988). Proc. Natl. Acad. Sci. USA, 85, 9312–9316.

  • Daley GQ, Van Etten RA and Baltimore D . (1990). Science, 247, 824–830.

  • Dang CV . (1999). Mol. Cell. Biol., 19, 1–11.

  • Dasari VK, Goharderakhshan RZ, Perinchery G, Li LC, Tanaka Y, Alonzo J and Dahiya R . (2001). J. Urol., 165, 1335–1341.

  • Deininger MW, Vieira S, Mendiola R, Schultheis B, Goldman JM and Melo JV . (2000). Cancer Res., 60, 2049–2055.

  • Deininger MW, Vieira SA, Parada Y, Banerji L, Lam EW, Peters G, Mahon FX, Kohler T, Goldman JM and Melo JV . (2001). Cancer Res., 61, 8005–8013.

  • Dotti G, Garattini E, Borleri G, Masuhara K, Spinelli O, Barbui T and Rambaldi A . (1999). Br. J. Haematol., 105, 163–172.

  • Dua K, Williams TM and Beretta L . (2001). Proteomics, 1, 1191–1199.

  • Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. USA, 95, 14863–14868.

  • Epner DE and Koeffler HP . (1990). Ann. Intern. Med., 113, 3–6.

  • Fang G . (2002). Mol. Biol. Cell, 13, 755–766.

  • Fukada T and Tonks NK . (2001). J. Biol. Chem., 276, 25512–25519.

  • Gishizky ML and Witte ON . (1992). Science, 256, 836–839.

  • Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES . (1999). Science, 286, 531–537.

  • Grimley PM, Dong F and Rui H . (1999). Cytokine Growth Factor Rev., 10, 131–157.

  • Hao SX and Ren R . (2000). Mol. Cell. Biol., 20, 1149–1161.

  • Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Loffler H, Hochhaus A and Heinze B et al. (1994). Blood, 84, 4064–4077.

  • Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK and Groffen J . (1990). Nature, 344, 251–253.

  • Hofmann WK, de Vos S, Elashoff D, Gschaidmeier H, Hoelzer D, Koeffler HP and Ottmann OG . (2002). Lancet, 359, 481–486.

  • Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P and Ohgaki H . (2000). Cancer Res., 60, 6868–6874.

  • Itoh M, Oida E, Iwai K, Okazaki T, Tashima M and Uchiyama T . (2001). Rinsho Ketsueki, 42, 209–215.

  • Janeway Jr CA and Medzhitov R . (2002). Annu. Rev. Immunol., 20, 197–216.

  • Janowska-Wieczorek A, Majka M, Marquez-Curtis L, Wertheim JA, Turner AR and Ratajczak MZ . (2002). Leukemia, 16, 1160–1166.

  • Jena N, Deng M, Sicinska E, Sicinski P and Daley GQ . (2002). Cancer Res., 62, 535–541.

  • Johansson B, Fioretos T and Mitelman F . (2002). Acta Haematol., 107, 76–94.

  • Kelliher MA, McLaughlin J, Witte ON and Rosenberg N . (1990). Proc. Natl. Acad. Sci. USA, 87, 6649–6653.

  • Maio M, Brasoveanu LI, Coral S, Sigalotti L, Lamaj E, Gasparollo A, Visintin A, Altomonte M and Fonsatti E . (1998). Int. J. Oncol., 13, 305–318.

  • Majsterek I, Blasiak J, Mlynarski W, Hoser G and Skorski T . (2002). Cell Biol. Int., 26, 363–370.

  • Mayor T, Stierhof YD, Tanaka K, Fry AM and Nigg EA . (2000). J. Cell. Biol., 151, 837–846.

  • McLaughlin J, Chianese E and Witte ON . (1987). Proc. Natl. Acad. Sci. USA, 84, 6558–6562.

  • Merdes A, Heald R, Samejima K, Earnshaw WC and Cleveland DW . (2000). J. Cell. Biol., 149, 851–862.

  • Nieborowska-Skorska M, Hoser G, Kossev P, Wasik MA and Skorski T . (2002). Blood, 99, 4531–4539.

  • Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B and Skorski T . (1999). J. Exp. Med., 189, 1229–1242.

  • Ohmine K, Ota J, Ueda M, Ueno S, Yoshida K, Yamashita, Y, Kirito K, Imagawa S, Nakamura Y, Saito K, Akutsu M, Mitani K, Kano Y, Komatsu N, Ozawa K and Mano H . (2001). Oncogene, 20, 8249–8257.

  • Olesen SH, Thykjaer T and Orntoft TF . (2001). Carcinogenesis, 22, 813–815.

  • Parada Y, Banerji L, Glassford J, Lea NC, Collado M, Rivas C, Lewis JL, Gordon MY, Thomas NS and Lam EW . (2001). J. Biol. Chem., 276, 23572–23580.

  • Peled A, Hardan I, Trakhtenbrot L, Gur E, Magid M, Darash-Yahana M, Cohen N, Grabovsky V, Franitza S, Kollet O, Lider O, Alon R, Rechavi G and Lapidot T . (2002). Stem Cells, 20, 259–266.

  • Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR and Calabretta B . (1998). EMBO J., 17, 4442–4455.

  • Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA and Calabretta B . (2002). Nat. Genet., 30, 48–58.

  • Pierce A, Spooncer E, Ainsworth S and Whetton AD . (2002). Oncogene, 21, 3068–3075.

  • Raitano AB, Halpern JR, Hambuch TM and Sawyers CL . (1995). Proc. Natl. Acad. Sci. USA, 92, 11746–11750.

  • Raitano AB, Whang YE and Sawyers CL . (1997). Biochim. Biophys. Acta, 1333, F201–F216.

  • Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES and Golub TR . (2001). Proc. Natl. Acad. Sci. USA, 98, 15149–15154.

  • Ratajczak MZ, Hijiya N, Catani L, DeRiel K, Luger SM, McGlave P and Gewirtz AM . (1992). Blood, 79, 1956–1961.

  • Reuther JY, Reuther GW, Cortez D, Pendergast AM and Baldwin Jr AS . (1998). Genes Dev., 12, 968–981.

  • Salgia R, Quackenbush E, Lin J, Souchkova N, Sattler M, Ewaniuk DS, Klucher KM, Daley GQ, Kraeft SK, Sackstein R, Alyea EP, von Andrian UH, Chen LB, Gutierrez-Ramos JC, Pendergast AM and Griffin JD . (1999). Blood, 94, 4233–4246.

  • Sattler M and Griffin JD . (2001). Int. J. Hematol., 73, 278–291.

  • Sattler M and Salgia R . (1997). Cytokine Growth Factor Rev., 8, 63–79.

  • Sattler M, Verma S, Byrne CH, Shrikhande G, Winkler T, Algate PA, Rohrschneider LR and Griffin JD . (1999). Mol. Cell. Biol., 19, 7473–7480.

  • Sawyers CL, Callahan W and Witte ON . (1992). Cell, 70, 901–910.

  • Schadt EE, Li C, Su C and Wong WH . (2000). J. Cell. Biochem., 80, 192–202.

  • Shah JV and Cleveland DW . (2000). Cell, 103, 997–1000.

  • Shtivelman E, Lifshitz B, Gale RP, Roe BA and Canaani E . (1986). Cell, 47, 277–284.

  • Skorski T . (2002). Nat. Rev. Cancer, 2, 351–360.

  • Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B and Calabretta B . (1998). Blood, 91, 406–418.

  • Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R and Skorski T . (2001). Mol. Cell, 8, 795–806.

  • Soto T, Fernandez J, Vicente-Soler J, Cansado J and Gacto M . (1999). Appl. Environ. Microbiol., 65, 2020–2024.

  • Tauchi T, Yoshimura A and Ohyashiki K . (2001). Exp. Hematol., 29, 356–361.

  • van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.

  • Vieira SA, Deininger MW, Sorour A, Sinclair P, Foroni L, Goldman JM and Melo JV . (2001). Genes Chromosom. Cancer, 32, 353–363.

  • Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, Herzenberg LA and Steinman L . (2000). Proc. Natl. Acad. Sci. USA, 97, 2680–2685.

  • Wildi S, Kleeff J, Maruyama H Maurer CA, Buchler MW and Korc M . (2001). Gut, 49, 409–417.

  • Wodicka L, Dong H, Mittmann M, Ho MH and Lockhart DJ . (1997). Nat. Biotechnol., 15, 1359–1367.

  • Xie K . (2001). Cytokine Growth Factor Rev., 12, 375–391.

  • Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L and Downing JR . (2002). Cancer Cell, 1, 133–143.

  • Zou X and Calame K . (1999). J. Biol. Chem., 274, 18141–18144.

Download references

Acknowledgements

This work was supported in part by NIH CA87300 and American Cancer Society Grant RSG-98-348-04-LIB (TS) and in part by Deutsche Forschungsgemeinschaft grant Fi 405/4-2 and José Carreras Leukämie-Stiftung e.V. grant (TF). T Skorski is a Scholar of the Leukemia and Lymphoma Society.

Author information

Authors and Affiliations

  1. Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, 19122, PA, USA

    Michal Oskar Nowicki & Tomasz Skorski

  2. Department of Pathology, UC Irvine College of Medicine, Orange, 92868, CA, USA

    Peter Pawlowski & Tomasz Pawlowski

  3. III Medical Department, The Johannes Guttenberg University, Mainz, 55131, Germany

    Thomas Fischer & Georg Hess

Authors
  1. Michal Oskar Nowicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Pawlowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georg Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomasz Pawlowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tomasz Skorski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomasz Skorski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nowicki, M., Pawlowski, P., Fischer, T. et al. Chronic myelogenous leukemia molecular signature. Oncogene 22, 3952–3963 (2003). https://doi.org/10.1038/sj.onc.1206620

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206620

Keywords

This article is cited by

Search

Advanced search

Quick links